Cision PR Newswire

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn’s Disease and Ulcerative Colitis at ACG 2026

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...

METABORA GAMES and Baligames to Participate in ‘WebX 2025’ and Showcase New Title ‘Puzzle & Guardians’

Core partner of LINE NEXT and Kaia DLT Foundation's "Mini Dapp Station" at Japan's largest Web3 conference Unveiling a...

PPA Tour Asia is bringing Back-to-Back Cups to Malaysia and Vietnam

SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- Two straight weeks of pure pickleball action is on the horizon, with PPA Tour Asia bringing back-to-back Cups to...

Longbridge Group Collaborates with Cboe to Expand Global Index Offering, Enhancing Investor Access to Key Market Data

SINGAPORE, Aug. 25, 2025 /PRNewswire/ -- Longbridge Group, a leading financial technology innovator, today announced that it has added the Cboe Global Indices Feed...

Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung...

SAN FRANCISCO and SUZHOU, China, Aug. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing...